Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caffeine Therapy in Preterm Infants Born at 28-34 Weeks: A Pilot Placebo-Controlled Randomized Controlled Trial

NCT07456670 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT07456670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07456670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caffeine Therapy in Preterm Infants Born at 28-34 Weeks: A Pilot Placebo-Controlled Randomized Controlled Trial
Lead sponsor
Queen's University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

caffeine, neonatal outcomes, preterm birth